|
ATF7IP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.907000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.377200E-01 |
| Normal-vs-Stage2 |
9.883000E-01 |
| Normal-vs-Stage3 |
3.626400E-01 |
| Normal-vs-Stage4 |
3.155400E-01 |
| Stage1-vs-Stage2 |
4.928000E-01 |
| Stage1-vs-Stage3 |
4.414000E-02 |
| Stage1-vs-Stage4 |
4.988100E-02 |
| Stage2-vs-Stage3 |
4.781000E-01 |
| Stage2-vs-Stage4 |
4.199200E-01 |
| Stage3-vs-Stage4 |
8.877600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.317000E-01 |
| Normal-vs-AfricanAmerican |
1.445810E-02 |
| Normal-vs-Asian |
8.447800E-02 |
| Caucasian-vs-AfricanAmerican |
4.222300E-03 |
| Caucasian-vs-Asian |
1.885150E-01 |
| AfricanAmerican-vs-Asian |
1.800040E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.631800E-01 |
| Normal-vs-Female |
9.129800E-01 |
| Male-vs-Female |
8.522400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.596200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.203200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.732600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.323180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.611400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.646200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.458400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.382370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.992200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.498200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.411400E-01 |
| Normal-vs-Grade 2 |
3.894000E-01 |
| Normal-vs-Grade 3 |
5.652800E-01 |
| Normal-vs-Grade 4 |
4.143200E-01 |
| Grade 1-vs-Grade 2 |
5.524400E-01 |
| Grade 1-vs-Grade 3 |
2.210000E-01 |
| Grade 1-vs-Grade 4 |
2.047000E-01 |
| Grade 2-vs-Grade 3 |
9.525900E-02 |
| Grade 2-vs-Grade 4 |
1.092210E-01 |
| Grade 3-vs-Grade 4 |
6.555400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.748400E-02 |
| Normal-vs-ccB subtype |
8.816800E-01 |
| ccA subtype-vs-ccB subtype |
7.254400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.563400E-01 |
| Normal-vs-N1 |
9.205200E-01 |
| N0-vs-N1 |
9.015400E-01 |
|
|
